These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7242313)

  • 1. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
    G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
    Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
    Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is isosorbide mononitrate better than the dinitrate?
    Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release isosorbide mononitrate for angina.
    Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
    Nyberg G
    Int J Cardiol; 1997 Jun; 60(1):107-10. PubMed ID: 9209948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
    Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
    Fazzini PF; Pucci P
    Cardiologia; 1987 Nov; 32(11):1297-302. PubMed ID: 3447703
    [No Abstract]   [Full Text] [Related]  

  • 15. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
    Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur).
    Kendall MJ
    J Clin Pharm Ther; 1990 Jun; 15(3):169-85. PubMed ID: 2195051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
    Stauch M; Grewe N
    Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in the use of nitrates for treatment of angina pectoris.
    Ankier SI; Warrington SJ; Sneddon JM
    J Int Med Res; 1988; 16(4):249-56. PubMed ID: 3139481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
    Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
    Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.